These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20363214)

  • 61. [Biomarkers in heart failure: an update].
    Emdin M; Barison A; Passino C; Vergaro G
    G Ital Cardiol (Rome); 2013 Dec; 14(12):809-16. PubMed ID: 24336596
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Emerging biomarkers for heart failure: an update.
    Dalzell JR; Cannon JA; Jackson CE; Lang NN; Gardner RS
    Biomark Med; 2014; 8(6):833-40. PubMed ID: 25224939
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Biomarkers in heart failure.
    Eleuteri E; Di Stefano A
    Minerva Cardioangiol; 2012 Apr; 60(2):213-26. PubMed ID: 22495170
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Targeting urocortin signaling pathways to enhance cardioprotection: is it time to move from bench to bedside?
    Onorati F; Chen-Scarabelli C; Knight R; Stephanou A; Mohanti B; Santini F; Tessari M; Kini A; Narula J; Saravolatz L; Mazzucco A; Scarabelli T; Faggian G
    Cardiovasc Drugs Ther; 2013 Oct; 27(5):451-63. PubMed ID: 23824484
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Urocortin in dogs: a new platform to develop future research in veterinary cardiology.
    Zini E
    Vet J; 2011 Jun; 188(3):258-9. PubMed ID: 20675159
    [No Abstract]   [Full Text] [Related]  

  • 66. Zinc and cardiovascular disease.
    Little PJ; Bhattacharya R; Moreyra AE; Korichneva IL
    Nutrition; 2010; 26(11-12):1050-7. PubMed ID: 20950764
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Urocortins as biomarkers in cardiovascular disease.
    Vasconcelos I; Adão R; Rademaker MT; Leite-Moreira AF; Fontes-Sousa AP; Brás-Silva C
    Clin Sci (Lond); 2022 Jan; 136(1):1-14. PubMed ID: 34939089
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Assessment of clinical data on urocortins and their therapeutic potential in cardiovascular diseases: A systematic review and meta-analysis.
    Kovács DK; Farkas N; Soós A; Hegyi P; Kelava L; Eitmann S; Schekk A; Molnár Z; Erőss B; Balaskó M
    Clin Transl Sci; 2021 Nov; 14(6):2461-2473. PubMed ID: 34378854
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Further evidence to support a role for urocortin 2 in heart failure.
    Moxon JV; Emeto TI; Golledge J
    Anadolu Kardiyol Derg; 2012 Mar; 12(2):121-2. PubMed ID: 22281791
    [No Abstract]   [Full Text] [Related]  

  • 70. Update on the diagnosis and management of acute heart failure.
    Gouda P; Ezekowitz JA
    Curr Opin Cardiol; 2019 Mar; 34(2):202-206. PubMed ID: 30547895
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The challenge of drug development in acute heart failure: balancing mechanisms, targeting patients, and gambling on outcomes.
    Pang PS; Givertz MM
    JACC Heart Fail; 2013 Oct; 1(5):442-4. PubMed ID: 24621977
    [No Abstract]   [Full Text] [Related]  

  • 72. Potential Markers in Cardiac Hypertrophy?
    Malinowski B; Fulgheri G; Wicinski M; Grzesk E; Odrowaz-Sypniewska G; Grześk G; Darwish N
    EJIFCC; 2012 Jul; 23(2):41-6. PubMed ID: 27683411
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Beyond appetite regulation: Targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss.
    Christoffersen BØ; Sanchez-Delgado G; John LM; Ryan DH; Raun K; Ravussin E
    Obesity (Silver Spring); 2022 Apr; 30(4):841-857. PubMed ID: 35333444
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Current Landscape of Heart Failure Gene Therapy.
    Kieserman JM; Myers VD; Dubey P; Cheung JY; Feldman AM
    J Am Heart Assoc; 2019 May; 8(10):e012239. PubMed ID: 31070089
    [No Abstract]   [Full Text] [Related]  

  • 75. Cardiovascular effects of urocortin 2 and urocortin 3 in patients with chronic heart failure.
    Stirrat CG; Venkatasubramanian S; Pawade T; Mitchell AJ; Shah AS; Lang NN; Newby DE
    Br J Clin Pharmacol; 2016 Oct; 82(4):974-82. PubMed ID: 27275843
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Direct localisation of molecules in tissue sections of growing antler tips using MALDI imaging.
    Deb-Choudhury S; Wang W; Clerens S; McMahon C; Dyer JM; Li C
    Mol Cell Biochem; 2015 Nov; 409(1-2):225-41. PubMed ID: 26260050
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Vascular effects of urocortins 2 and 3 in healthy volunteers.
    Venkatasubramanian S; Griffiths ME; McLean SG; Miller MR; Luo R; Lang NN; Newby DE
    J Am Heart Assoc; 2013 Jan; 2(1):e004267. PubMed ID: 23525432
    [TBL] [Abstract][Full Text] [Related]  

  • 78. First survey and functional annotation of prohormone and convertase genes in the pig.
    Porter KI; Southey BR; Sweedler JV; Rodriguez-Zas SL
    BMC Genomics; 2012 Nov; 13():582. PubMed ID: 23153308
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Novel therapeutic targets for the treatment of heart failure.
    Tamargo J; López-Sendón J
    Nat Rev Drug Discov; 2011 Jun; 10(7):536-55. PubMed ID: 21701502
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Corticotropin-releasing factor family and its receptors: pro-inflammatory or anti-inflammatory targets in the periphery?
    Zhu H; Wang J; Li J; Li S
    Inflamm Res; 2011 Aug; 60(8):715-21. PubMed ID: 21476084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.